| Element List | Explanation |
|---|---|
| Introduction | Miral Medical Clinics Company announces to its shareholders the results of the Ordinary General Assembly Meeting (First Meeting), which was held at 7:15 PM on Monday, 22/12/1447 AH, corresponding to 08/06/2026 AD, at the company's headquarters located in Riyadh – Al Olaya District – Al Tahlia Street, via modern technology – using Tadawulaty services; after the legal quorum for the validity of the meeting was met. |
| City and Location of the General Assembly's Meeting | At the company's headquarters located in Riyadh – Al Olaya District – Al Tahlia Street, using modern technology – Tadawulaty services |
| Date of the General Assembly's Meeting | 2026-06-08 Corresponding to 1447-12-22 |
| Time of the General Assembly’s Meeting | 19:15 |
| Percentage of Attending Shareholders | %67.59 |
| Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees | 1. Dr. Bandar Burjas Hamidi Al-Abdulkarim – Chairman of the Board 2. Dr. Yasser Ibrahim Abdulkarim Al-Obaida – Vice Chairman of the Board 3. Dr. Sami Abdullah Dakhilallah Al-Saeed – Managing Director and CEO 4. Mr. Ali Abdullah Ali Al-Saqiyah – Board Member 5. Mr. Osama Saleh Ibrahim Al-Hadithi – Board Member |
| Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf | 1. Professor Osama Saleh Ibrahim Al-Hadithi - Chairman of the Review Committee |
| Voting Results on the Items of the General Assembly's Meeting Agenda's | 1. Approval of the company's auditor's report for the fiscal year ending December 31, 2025, after discussion. 2. Review and discussion of the Board of Directors' report for the fiscal year ending December 31, 2025. 3. Review and discussion of the company's financial statements for the fiscal year ending December 31, 2025. 4. Approval of the discharge of the Board of Directors from liability for the fiscal year ending December 31, 2025. 5. Approval of the appointment of Maham Professional Consulting Company as the company's auditor from among the candidates, based on the recommendation of the Audit Committee. This is for the examination, review, and auditing of the company's preliminary financial statements for the first quarter ending March 31, 2026, the second quarter ending June 30, 2026, the third quarter ending September 30, 2026, and the annual financial statements ending December 31, 2026, for a fee of SAR 315,000 (three hundred and fifteen thousand Saudi Riyals). 6. Approval to authorize the Board of Directors to distribute interim dividends to shareholders on a semi-annual or quarterly basis for the fiscal year ending December 31, 2026. 7. Approval to authorize the Board of Directors with the powers of the Ordinary General Assembly to authorize the distribution of dividends as stipulated in paragraph (1) of Article Twenty-Seven of the Companies Law, for a period of one year from the date of approval by the General Assembly or until the end of the term of the authorized Board of Directors, whichever is earlier, in accordance with the conditions stipulated in the Implementing Regulations of the Companies Law pertaining to listed joint-stock companies. 8. Approval of the transactions and contracts between the company and the CEO and Managing Director (Dr. Sami Abdullah Al-Saeed), in which he has a direct interest. These transactions consist of salaries, commissions, and bonuses, and commenced in 2025. The total value of these transactions during 2025 amounted to SAR 1,244,957. These transactions are conducted within the normal course of business and in accordance with prevailing commercial terms and conditions, without any preferential terms. 9. Approval of the amendment to the policy and criteria for remuneration of members of the Board of Directors, its subcommittees, and the executive management. |
| Additional Information | Not applicable |
Miral Dental Clinics Co. Announces the Results of the Ordinary General Assembly Meeting (First Meeting)
AI Summary
- Miral Medical Clinics Company shareholders approved the financial statements, auditor's report, and Board report for the fiscal year ending December 31, 2025, with a 67.59% attendance rate.
- Authorized the Board of Directors to distribute interim dividends on a semi-annual or quarterly basis for the 2026 fiscal year.
- Appointed Maham Professional Consulting Company as the auditor for FY 2026 for a fee of SAR 315,000 and discharged the Board of Directors from liability for the 2025 fiscal year.
- Approved 2025 transactions totaling SAR 1,244,957 with CEO Dr. Sami Abdullah Al-Saeed and authorized amendments to the remuneration policy for the Board and executive management.
